Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

COVID-19 5Neoplasms 2Hematologic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hematopoietic and Lymphatic System Neoplasm 1Chronic Disease 1

Interventions

Registries 2thymoglobulin 1fludarabine phosphate 1fludarabine 1Telemedicine 1Surveys and Questionnaires 1Soybean Proteins 1Risk Factors 1Phlebotomy 1Nutritional Status 1Nutrition Assessment 1Mycophenolic Acid 1Methods 1Imagery, Psychotherapy 1Health Communication 1Health 1Fitness Trackers 1FIBS 1Exercise 1Cyclosporine 1Cause of Death 1COVID-19 Vaccines 1Busulfan 1BNT162 Vaccine 1Antilymphocyte Serum 1Activities of Daily Living 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Chronic Disease × BNT162 Vaccine × Clear all
NCT04743388 2022-04-11

Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System

National and Kapodistrian University of Athens

Unknown
600 enrolled
Other hematologic neoplasm

COVID-19, Chronic Disease, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡